Seastar Medical Hldg Corp (ICU) Stock Price, Quote & News

Company Profile

SeaStar Medical Holding Corporation, a commercial-stage medical device company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI)...

Industry: Biotechnology

Sector: Healthcare

Phone: 844 427 8100

Website: seastarmedical.com

Address:

3513 Brighton Boulevard, Suite 410, Denver, United States

Ubiquitinacious Mar. 25 at 3:31 AM

$ICU green on the 3 month mfers

0 · Reply

CanadianDreamcast Mar. 24 at 11:09 PM

$ICU make me look like an idiot. Please 🙏

0 · Reply

Nikki7220 Mar. 24 at 9:04 PM

$ICU Under $10M market cap, a big gift. TOMORROW will tell. Does anyone see this company BK with so many awards?

0 · Reply

tobyford84 Mar. 24 at 8:10 PM

$ICU that was me, I bought 85k for my dog so that one day he can buy himself an edible schlorff

1 · Reply

josh77 Mar. 24 at 8:04 PM

$ICU added....

0 · Reply

Nikki7220 Mar. 24 at 7:58 PM

$ICU Been adding for tomorrow. Point of no return.

0 · Reply

SparkyReturns Mar. 24 at 7:40 PM

$ICU One day you'll see. One day.... Maybe not tomorrow, but one day. GL longs!

1 · Reply

ljstonks Mar. 24 at 7:35 PM

$ICU bought another 225 in preparation for some imminent news!!

0 · Reply

Jw242 Mar. 24 at 7:26 PM

$ICU some dumbass just got 85k shares

0 · Reply

BULLISH1975 Mar. 24 at 7:18 PM

$ICU I would be happy with 25 pediatric hospitals by year end but I think/expect we could add even more with SAVE being removed in coming weeks or months!!!! lots if left field news possible too. either way, holding on strong!!

1 · Reply

SeaStar Medical to Report Fourth Quarter and Year-End 2025 Financial Results on March 25, 2026

Mar 9, 2026, 8:35 AM EDT - 15 days ago

SeaStar Medical to Present at the Life Sciences Investor Forum on March 11th

Mar 5, 2026, 8:20 AM EST - 19 days ago

SeaStar Medical Announces Completion of FDA Enrollment Requirement for SAVE Surveillance Registry Evaluating QUELIMMUNE Safety for Pediatric AKI

Feb 9, 2026, 8:20 AM EST - 6 weeks ago

SeaStar Medical Announces Publication in Pediatric Nephrology of Positive Real-World Experience for QUELIMMUNE™ (SCD-PED) Therapy in Pediatric Acute Kidney Injury (AKI)

Jan 29, 2026, 8:25 AM EST - 7 weeks ago

SeaStar Medical to Present at Upcoming Noble Capital Markets Emerging Growth Virtual Equity Conference

Jan 7, 2026, 8:13 AM EST - 2 months ago

SeaStar Medical Announces 2026 Milestones

Jan 6, 2026, 8:53 AM EST - 2 months ago

SeaStar Medical to Present at Upcoming Biotech Showcase 2026 Investor Conference

Dec 23, 2025, 4:25 PM EST - 3 months ago

SeaStar Medical Announces 1-for-10 Reverse Split

Dec 2, 2025, 8:27 AM EST - 4 months ago

SeaStar Medical Announces FDA Approval of Reduction in Mandatory Enrollment for SAVE Surveillance Registry Evaluating QUELIMMUNE™ Safety for Pediatric AKI

Nov 20, 2025, 9:52 AM EST - 4 months ago

SeaStar Medical to Present at Upcoming NobleCon21 Investor Conference

Nov 17, 2025, 8:43 AM EST - 4 months ago

SeaStar Medical Announces Appointment of Michael Messinger as CFO

Nov 13, 2025, 4:05 PM EST - 4 months ago

SeaStar Medical Reports Third Quarter 2025 Financial Results and Provides Business Updates

Nov 5, 2025, 10:03 AM EST - 4 months ago

SeaStar Medical to Report Third Quarter Financial Results on November 13, 2025

Sep 29, 2025, 8:36 AM EDT - 6 months ago

SeaStar Medical Reports Positive Early Results for QUELIMMUNE Therapy in Pediatric Acute Kidney Injury (AKI) at the 5th International Symposium on Acute Kidney Injury in Children

Sep 24, 2025, 4:22 PM EDT - 6 months ago

SeaStar Medical Reports DSMB Recommendation to Continue the NEUTRALIZE-AKI Pivotal Trial in Adult Acute Kidney Injury

Sep 23, 2025, 8:23 AM EDT - 6 months ago

SeaStar Medical to Present Early SAVE Registry Data of QUELIMMUNE in Pediatric Acute Kidney Injury at the 5th International Symposium on Acute Kidney Injury in Children

Sep 4, 2025, 6:13 PM EDT - 7 months ago

SeaStar Medical to Participate in the HC Wainwright 27th Annual Global Investment Conference

Sep 2, 2025, 8:22 AM EDT - 7 months ago

SeaStar Medical Announces Newly Published QUELIMMUNE Health Economic Study Projecting Significantly Reduced Health Care Costs in the Treatment of Pediatric AKI due to Estimated Shorter Hospital Stays and Increased Survival

Aug 13, 2025, 4:05 PM EDT - 7 months ago

SeaStar Medical Reports Second Quarter 2025 Financial Results and Provides Business Updates

Aug 7, 2025, 10:00 AM EDT - 8 months ago

SeaStar Medical to Report Second Quarter Financial Results on August 13, 2025

Aug 6, 2025, 8:33 AM EDT - 8 months ago

SeaStar Medical Reaches New Enrollment Milestone in NEUTRALIZE-AKI Pivotal Trial of SCD Therapy for Adult Patients with Acute Kidney Injury (AKI)

Jul 31, 2025, 3:01 PM EDT - 8 months ago

SeaStar Medical Announces $4.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Jul 22, 2025, 8:20 AM EDT - 8 months ago

SeaStar Medical Reports Positive Results for QUELIMMUNE Therapy in Pediatric Acute Kidney Injury (AKI) from the First 20 SAVE Surveillance Registry Patients

Jul 16, 2025, 8:45 AM EDT - 8 months ago

SeaStar Medical Grows Customer Base and Expands QUELIMMUNE Surveillance Registry

Jul 10, 2025, 3:29 PM EDT - 9 months ago

SeaStar Medical Announces $4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Jul 8, 2025, 8:05 AM EDT - 9 months ago

SeaStar Medical Expands QUELIMMUNE Adoption for Critically Ill Pediatric Patients with Acute Kidney Injury (AKI)

Jul 2, 2025, 4:25 PM EDT - 9 months ago

SeaStar Medical Announces Positive Nasdaq Listing Determination

Jun 25, 2025, 8:05 AM EDT - 9 months ago

SeaStar Medical Reports Update on Nasdaq Listing Status

Jun 24, 2025, 9:05 AM EDT - 9 months ago

SeaStar Medical Announces Two Feature Stories on QUELIMMUNE Adoption and Patient Testimonial of Life-Saving Therapy

Jun 20, 2025, 12:10 PM EDT - 9 months ago

SeaStar Medical Announces Pricing of Up to $8 Million Public Offering

Jun 11, 2025, 8:25 AM EDT - 10 months ago

AREVA Institute and SeaStar Medical Announce DoD Award of Prestigious Military Grant to AREVA Institute to Evaluate SeaStar Medical's SCD Therapy to Advance Breakthrough Burn and Sepsis Research

May 28, 2025, 8:05 AM EDT - 10 months ago

SeaStar Medical Announces CMS Coverage for Medicare and Medicaid Eligible Patients with Cardiorenal Syndrome Awaiting LVAD in Investigational Trial of SCD Therapy

May 14, 2025, 4:05 PM EDT - 11 months ago

SeaStar Medical Reports First Quarter 2025 Financial Results and Provides Business Updates

May 13, 2025, 8:05 AM EDT - 11 months ago

SeaStar Medical Reaches Interim Enrollment Target for NEUTRALIZE-AKI Pivotal Trial of SCD Therapy for Adult Patients with Acute Kidney Injury

May 7, 2025, 10:00 AM EDT - 11 months ago

SeaStar Medical to Report First Quarter Financial Results on May 14, 2025

Apr 30, 2025, 8:05 AM EDT - 11 months ago

SeaStar Medical Announces CEO Interview on Benzinga All Access to Occur Today at Approximately 10:50 am Eastern Time

Apr 8, 2025, 8:05 AM EDT - 1 year ago

FDA Grants SeaStar Medical Two New Breakthrough Device Designations for SCD Therapy to Treat Systemic Inflammatory Response in Adult and Pediatric Patients Undergoing Cardiac Surgery

Mar 27, 2025, 4:05 PM EDT - 1 year ago

SeaStar Medical Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates

Mar 24, 2025, 5:30 PM EDT - 1 year ago

SeaStar Medical to Report Fourth Quarter and Year-End 2024 Financial Results on March 27, 2025

Mar 18, 2025, 8:45 AM EDT - 1 year ago

NKF Honors SeaStar Medical, with 2025 Corporate Innovator Award

Feb 3, 2025, 4:05 PM EST - 1 year ago

SeaStar Medical Announces Closing of $6 Million Registered Direct Offering Priced At-the-Market

Jan 22, 2025, 7:30 AM EST - 1 year ago

SeaStar Medical Activates 15th Site for its Adult Acute Kidney Injury Pivotal Trial

Jan 13, 2025, 8:30 AM EST - 1 year ago

FDA Approves Feasibility Study with SeaStar Medical's Selective Cytopheretic Device in Adults with Cardiorenal Syndrome

Jan 8, 2025, 8:30 AM EST - 1 year ago

SeaStar Medical Begins Shipping QUELIMMUNE to a Fourth Hospital Customer

Dec 23, 2024, 7:00 AM EST - 1 year ago

SeaStar Medical Activates 14th Hospital for its Adult AKI Pivotal Trial

Dec 11, 2024, 6:30 AM EST - 1 year ago

SeaStar Medical Projects Multibillion-Dollar Market Potential for its Selective Cytopheretic Device in Initial Target Indications

Dec 4, 2024, 8:30 AM EST - 1 year ago

SeaStar Medical to Hold Business Update Conference Call on December 11, 2024

Nov 26, 2024, 8:00 AM EST - 1 year ago

SeaStar Medical to Present at Noble Capital Markets' NobleCon20 on December 4, 2024

Nov 22, 2024, 8:30 AM EST - 1 year ago

Leading Independent Proxy Advisory Firms ISS and Glass Lewis Support SeaStar Medical's Proposals to Ratify the Issuance of Shares and to Reduce the Number of Authorized Shares

Nov 15, 2024, 8:30 AM EST - 1 year ago

SeaStar Medical Reaches Milestone of 100th QUELIMMUNE Commercial Device as Shipments Begin to its Third Hospital Customer

Ubiquitinacious Mar. 25 at 3:31 AM

$ICU green on the 3 month mfers

0 · Reply

CanadianDreamcast Mar. 24 at 11:09 PM

$ICU make me look like an idiot. Please 🙏

0 · Reply

Nikki7220 Mar. 24 at 9:04 PM

$ICU Under $10M market cap, a big gift. TOMORROW will tell. Does anyone see this company BK with so many awards?

0 · Reply

tobyford84 Mar. 24 at 8:10 PM

$ICU that was me, I bought 85k for my dog so that one day he can buy himself an edible schlorff

1 · Reply

josh77 Mar. 24 at 8:04 PM

$ICU added....

0 · Reply

Nikki7220 Mar. 24 at 7:58 PM

$ICU Been adding for tomorrow. Point of no return.

0 · Reply

SparkyReturns Mar. 24 at 7:40 PM

$ICU One day you'll see. One day.... Maybe not tomorrow, but one day. GL longs!

1 · Reply

ljstonks Mar. 24 at 7:35 PM

$ICU bought another 225 in preparation for some imminent news!!

0 · Reply

Jw242 Mar. 24 at 7:26 PM

$ICU some dumbass just got 85k shares

0 · Reply

BULLISH1975 Mar. 24 at 7:18 PM

1 · Reply

Yi_YandH Mar. 24 at 6:32 PM

$ICU BIG DAY TOMORROW. BIGGER DAY IN a week or 2 when the SAVE Registry is abolished by the FDA. 50 buying hospitals by year’s end……JMHO. A major Partnership for the Adult device’s sales, training and distribution, by year’s end….JMHO. European and, quite possibly, Asian customers, as well, by year’s end……JMHO. S….C….D, S…..C…..D, S……C……D.

1 · Reply

CanadianDreamcast Mar. 24 at 6:27 PM

$ICU the market would rather poor money into a.i. that takes our jobs and pills that don't heal us just cost a fortune and keep us chronically sick.

0 · Reply

CanadianDreamcast Mar. 24 at 6:26 PM

$ICU I'm a negative Nelly but I also find this really sad. We all know how amazing the SCD is and this world doesn't give a shit.

1 · Reply

Aznwactrackstar Mar. 24 at 5:58 PM

$ICU just here to say how sad this is, continuous decline. Super unfortunate. Its also sad that while theyre out posting on LinkedIn, they have no followers. I could post something right now and get more likes than them. Really hopeful that they can turn things around over the years.

1 · Reply

CanadianDreamcast Mar. 24 at 5:53 PM

$ICU disgusting

0 · Reply

Brad_7424 Mar. 24 at 5:00 PM

$ICU $1 is close, within the next month i'd say.

0 · Reply

tobyford84 Mar. 24 at 4:50 PM

$ICU the sheep were unnecessary anyway

0 · Reply

OfficialStocktwitsUser Mar. 24 at 4:46 PM

$ICU RSI: 33.90, MACD: -0.0804 Vol: 0.19, MA20: 2.51, MA50: 2.48 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

Poundsandliberals Mar. 24 at 4:44 PM

$ICU What are we saying today about the drop, permabulls, the same old baseless reasons (shorts are evil, tutes and others are trying to get your shares for cheap, big Pharma is sabotaging this)? Or do we have new lies we are telling ourselves. By the way, as long as the Chung hole abides, it will get Schlorffed.

1 · Reply

CanadianDreamcast Mar. 24 at 4:14 PM

$ICU as far as dilution Schlorff (dummy) should dilute every chance he can over 2.50 so he doesn't rip the bandaid off at 60cents. He's a disaster. Don't see the point of having a highly paid CEO who can't attract capital. He's a fat pig.

1 · Reply

CanadianDreamcast Mar. 24 at 4:09 PM

$ICU pretty clear the satanic rulers are manufacturing a global energy crisis. If you can't see Trump is satanic you're blind.

0 · Reply

Jw242 Mar. 24 at 3:23 PM

$ICU huge sell walls as always

0 · Reply

Market Cap	8.38M
Revenue (ttm)	140,000.00
Net Income (ttm)	-24.83M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-17,735.71%
Debt to Equity Ratio	0.00

Volume	177,300
Avg Vol	101,472
Day's Range	N/A - N/A
Shares Out	3.79M
Stochastic %K	21%
Beta	-1.04
Analysts	Strong Sell
Price Target	$9.00